產品描述: inS3-54A18 is a potent STAT3 inhibitor, with anti-cancer properties. |
靶點:
STAT3;STAT |
體外研究:
inS3-54A18 (5?μM) reduces wound healing to 64% and 76% for A549 and MDA-MB-231 cells, respectively. inS3-54A18 at 10?μM further reduces the healing to 47% and 39%, respectively. inS3-54A18 inhibits the expression of STAT3 downstream target genes and the binding of STAT3 to its endogenous target sequences. inS3-54A18 does not affect the constitutive or IL-6-induced STAT3 activation (Tyr705 phosphorylation) but represses STAT3 target gene (survivin) expression。 |
體內研究:
inS3-54A18 (200?mg/kg, p.o.) inhibits tumor growth, metastasis and expression of STAT3 target genes in a mouse xenograft model of A549 cells。 |
參考文獻:
1. Huang W, et al. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo. Oncogene. 2016 Feb 11;35(6):783-92 |
溶解性:
Soluble in DMSO |
保存條件:
-20°C |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
2.675 ml |
13.375 ml |
26.75 ml |
5 mM |
0.535 ml |
2.675 ml |
5.35 ml |
10 mM |
0.268 ml |
1.338 ml |
2.675 ml |
50 mM |
0.054 ml |
0.268 ml |
0.535 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |